Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
MicroVision (MVIS) Analyst Target of $2.50: What a +138% Move Would Require

MicroVision (MVIS) Analyst Target of $2.50: What a +138% Move Would Require

Key Takeaways

  • The central stock price target of $2.50 is the arithmetic mean of the verified analyst price targets used, which range from roughly $2.00 to $3.00.
  • With shares recently trading near $1.05, reaching $2.50 would require a gain of roughly 138% — a very large move.
  • Attributed targets include a $3.00 Buy from D. Boral Capital (Jason Kolbert) and a $2.00 Buy from WestPark Capital (Casey Ryan), reflecting a wide range of views.
  • The strongest supporting factors are MicroVision's industrial lidar product line and long-term demand in automation and defense; the biggest risks are minimal revenue and sustained losses.
  • The stock has declined sharply over the past year, falling from a 52-week high above $16 to under $2, which weighs on sentiment.

Analyst Price Targets and Consensus View

MicroVision, Inc. (MVIS) develops lidar sensors and perception software, including its MOVIA, MAVIN, IRIS, and HALO product lines. Coverage remains thin, and many targets predate the recent selloff, so I treat the analyst consensus with caution. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The most recent attributed targets range from a low of $2.00 (WestPark Capital's Casey Ryan, reiterated October 2025) to a high of $3.00 (D. Boral Capital's Jason Kolbert, maintained December 2025). Aggregators such as MarketScreener and Fintel show a mean near $2.50, with some sources citing a range as wide as roughly $2.02 to $3.15 across two to three analysts. The average of the verified targets is therefore about $2.50, which serves as the central target here.

The reasoning behind these Buy ratings centers on the long-term market for lidar in industrial automation, automotive, and defense rather than near-term financials. The wide $2.00–$3.00 spread signals meaningful disagreement about how quickly that demand might translate into revenue.

Current Market Position and Path Toward the Target

Shares recently closed near $1.05, toward the lower end of a 52-week range of roughly $0.98 to $16.05. Reaching the $2.50 average analyst price target implies upside of about 138%, which qualifies as a very large move, especially for a company with minimal current revenue.

The path to $2.50 would likely depend on commercial traction and a re-rating of the shares. MicroVision's revenue remains tiny — in the single-digit millions on a trailing basis — while the company continues to report substantial net losses and negative EPS. Against that backdrop, the stock's valuation is driven primarily by expectations of future lidar adoption rather than current profitability, leaving the market outlook highly sensitive to order announcements and customer progress.

What Could Support a Move Toward the Target

  • Industrial lidar demand. Beyond automotive, lidar is being adopted for warehouse automation, agriculture, mining, and security, expanding the addressable market.
  • Defense and industrial contracts. Any new customer wins or production agreements would be a material catalyst given the small revenue base.
  • Product breadth. The MOVIA, MAVIN, IRIS, and HALO lineup spans short- to long-range sensing, potentially broadening appeal across use cases.
  • Low market capitalization. At roughly $35–37 million, even modest positive news can produce outsized percentage moves in the share price.

What Could Prevent the Target From Being Reached

  • Persistent losses. Negative earnings and negative operating cash flow mean the company may need additional capital, which can dilute existing shareholders.
  • Concentrated competition. MicroVision competes against larger, better-funded lidar and sensor providers in a crowded market.
  • Slow revenue ramp. With only a few million dollars in trailing revenue, the gap between current results and what the targets imply is substantial.
  • Sentiment damage. The sharp multi-month decline and wide resistance level overhead could keep buyers cautious even if fundamentals improve.

Technical Levels and Market Structure

The shares are in a clear long-term downtrend, trading well below their 200-day moving average. The prior 52-week low near $0.98 acts as a key support level, while the area around $1.20–$1.30, where the stock consolidated before its latest leg lower, forms nearby resistance. The psychological $1.00 level is also notable. Because the stock has fallen from above $16, there is substantial overhead supply that would need to be absorbed for any sustained advance toward $2.50.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of roughly 12 months, though individual analysts differ and the targets cited here predate much of the recent decline. Investors should watch quarterly earnings and revenue, any customer or partnership announcements, gross margin trends, and the company's cash position and financing activity. Changes in analyst ratings or targets, along with broader risk appetite for speculative small-cap technology names, will also shape the price forecast.

Using AI Daily Buy/Sell Signals for MVIS

From what I see in volatile names like this, Tickeron's AI Daily Buy/Sell Signals provide a practical way to track momentum shifts without constant manual monitoring. The tool continuously analyzes thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. For a low-liquidity stock such as MVIS, it helps identify potential changes in trend as they develop, which can be useful when managing positions around key levels or upcoming catalysts.

Final Assessment

Can MVIS reach $2.50? The target is grounded in a small set of analyst Buy ratings averaging about $2.50, but the required move of roughly 138% from a price near $1.05 is very large, and the shares have been in a steep decline. Support rests on lidar demand in industrial and defense applications and a broad product lineup, while the principal obstacles are minimal revenue, sustained losses, possible dilution, and intense competition. With analysts split between $2.00 and $3.00, the wide range underscores genuine uncertainty. Investors should focus on revenue progression, cash runway, and any customer wins rather than treating the target as a near-term certainty.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MVIS

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


Momentum Indicator for MVIS turns negative, indicating new downward trend

MVIS saw its Momentum Indicator move below the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In 82 of the 91 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MVIS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

MVIS broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MVIS entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MVIS's RSI Indicator exited the oversold zone, 32 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +8.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where MVIS advanced for three days, in 206 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.721) is normal, around the industry mean (1.448). P/E Ratio (-0.210) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (32.028).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. MVIS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MVIS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 7.99B. The market cap for tickers in the group ranges from 12.56K to 120.89B. KYCCF holds the highest valuation in this group at 120.89B. The lowest valued company is FLXT at 12.56K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 5%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -13%. FCUV experienced the highest price growth at 130%, while ARAI experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 87%. For the same stocks of the Industry, the average monthly volume growth was 232% and the average quarterly volume growth was 107%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 50
Price Growth Rating: 61
SMR Rating: 78
Profit Risk Rating: 81
Seasonality Score: 6 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of display solutions for consumer electronic devices

Industry ElectronicEquipmentInstruments

Industry
Electronic Components
Address
18390 NE 68th Street
Phone
+1 425 936-6847
Employees
190
Web
https://www.microvision.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).